Literature DB >> 6194094

Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin.

U Fryksmark, K Ohlsson, M Rosengren, H Tegner.   

Abstract

The dominating inhibitor of leukocyte elastase in human respiratory tract secretions is a low molecular mass inhibitor, designated antileukoproteinase. An equimolar antileukoproteinase-elastase complex was produced and subjected to gel filtration after differing time intervals and was found to be stable. On addition to human serum, however, elastase dissociated from antileukoproteinase and formed a complex with alpha 1-proteinase inhibitor. A small amount of elastase was also found bound to alpha 2-macroglobulin. Antileukoproteinase was capable of inhibiting elastase bound to alpha 2-macroglobulin. This inhibition was more complete and more rapid when the alpha 2-macroglobulin-elastase complex was in a molar ratio of 1:1 than in a ratio of 1:2.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194094     DOI: 10.1515/bchm2.1983.364.2.793

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  5 in total

1.  Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases.

Authors:  C E Smith; D A Johnson
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

2.  Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor.

Authors:  M Bruch; J G Bieth
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

3.  Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.

Authors:  R A Stockley; H M Morrison; J A Kramps; J H Dijkman; D Burnett
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

4.  The transcriptome of Trichuris suis--first molecular insights into a parasite with curative properties for key immune diseases of humans.

Authors:  Cinzia Cantacessi; Neil D Young; Peter Nejsum; Aaron R Jex; Bronwyn E Campbell; Ross S Hall; Stig M Thamsborg; Jean-Pierre Scheerlinck; Robin B Gasser
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

5.  The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation.

Authors:  U Westin; M Nyström; I Ljungcrantz; B Eriksson; K Ohlsson
Journal:  Mediators Inflamm       Date:  2002-02       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.